The iStent inject, the latest MIGS device from Glaukos, has been approved for mild to moderate open-angle glaucoma in patients undergoing cataract surgery. Are you ready for it?
World-renowned ophthalmologist Thomas W. Samuelson, MD shares his surgical techniques and clinical results in this informative 60-minute webinar. Sightpath Medical is pleased to begin offering the iStent inject to your patients.
This webinar covers:
Surgical techniques and clinical results
Surgeon training
Reimbursement structure
How current Sightpath customers may access this technology
Complete the form at the right to view the webinar from Sightpath University.
Watch the Webinar
Enter your information below to access the Glaukos iStent inject webinar from Sightpath University.
Sightpath Medical is excited to share that we are working alongside Custom Surgical Partners to support the growing demand for office-based cataract surgery (OBS)
